Botulinum toxin in the management of acquired motor fusion deficiency.
Acquired disruption of motor fusion is a rare condition characterized by intractable diplopia. Management of these patients is extremely difficult. Prisms in any combination or even surgery may not help relieve their symptoms. We describe a longstanding case of acquired motor fusion disruption which was managed successfully with botulinum toxin injection.
Murthy
Ramesh
R
Department of Pediatric Ophthalmology and Strabismus, and Oculoplasty, Orbital diseases and Ocular Oncology, LV Prasad Eye Institute, Hyderabad, India. drrameshmurthy@gmail.com
Kesarwani
Siddharth
S
D000328:Adult; D019274:Botulinum Toxins, Type A / Q000008:administration & dosage*; D003867:Depth Perception / Q000502:physiology; D004172:Diplopia / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D004576:Electromyography; D005133:Eye Movements / Q000187:drug effects / Q000502:physiology; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D009465:Neuromuscular Agents / Q000008:administration & dosage*; D015835:Ocular Motility Disorders / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D009801:Oculomotor Muscles; D013285:Strabismus / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D014792:Visual Acuity
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A